About Careers MedBlog Contact us
Alpha-lipoic Acid Prevents Kidney Stones in Rare Genetic Disease

Alpha-lipoic Acid Prevents Kidney Stones in Rare Genetic Disease

Font : A-A+

  • Alpha-lipoic acid (ALA) is an anti-oxidant which naturally occurs in the body and in spinach, rice bran, brussel sprouts, organ meat.
  • ALA is also used as a supplement to treat nerve-related symptoms of diabetes and prevents cell damage.
  • Recently, ALA is found to dissolve cysteine crystals that is formed in the kidneys.

Cystinuria is a rare inherited disease that causes recurrent formation of painful and damaging kidney stones. High concentrations of the amino acid cystine is found in the urine, leading to the formation of cystine stones in the kidneys, ureter, and bladder

Alpha-lipoic acid, a dietary supplement widely available to consumers, prevented stone formation in a mouse model of cystinuria.

Listen to this article

Alpha-lipoic Acid Prevents Kidney Stones in Rare Genetic Disease

Researchers show that alpha-lipoic acid increased the solubility of the cystine crystals that collected in the urinary tracts of the mice. Alpha-lipoic acid is an anti-oxidant which naturally occurs in the body and in many foods. The supplement is approved in Germany to treat nerve-related symptoms of diabetes; it is thought to help prevent certain types of cell damage and is also used by consumers to treat degenerative eye and cardiovascular diseases.

"The effects were dramatic and unprecedented in this field," said Pankaj Kapahi, PhD, a professor at the Buck Institute and a senior co-author of the study, who noted that affected mice usually start developing cystine-laden kidney stones by three months of age.

"We were able to prevent stones from developing in young animals, and we significantly slowed the development of stones in animals that were already exhibiting the condition. We are excited that these results are moving to a clinical trial."

Senior co-author Marshall Stoller, MD, heads the urinary stone division at UCSF's Department of Urology and has had to perform repeat surgeries on patients with the disease. "These patients are in desperate need of new options," he said, adding that most currently available medications for cystinuria are decades old, not efficacious and associated with side effects.

Cystine stones don't always respond to extracorporeal shock wave therapy aimed at breaking the stones into small pieces to allow for spontaneous stone passage, and that dietary modifications have minimal impact on the disease.

Sign and symptoms of cystinuria includes: 1) hematuria- blood in the urine, 2) flank pain - pain in the side due to kidney pain, 3) renal colic - intense, cramping pain due to stones in the urinary tract, 4) obstructive uropathy- urinary tract disease due to obstruction, and 5) urinary tract infections.

In addition to providing hope for patients suffering from cystinuria, the research also uncovered a new role for alpha-lipoic acid. "Because it's an antioxidant, we thought the supplement would promote cystine metabolism in the mice," said Tiffany Zee, PhD, Study author.

"Surprisingly, that was not the case. Instead, we found that the supplement increased the solubility of the cystine stones, providing a new function for alpha-lipoic acid, one that should be of interest to other researchers." Zee is now working on pinpointing the specific metabolites and mechanisms by which alpha-lipoic acid solubilizes cystine. That work could be daunting.

"We estimate that there could be up to 100 metabolites that interact with cystine in human urine and there are differences in the metabolic systems between mice and humans," said Neelanjan Bose, PhD, a joint postdoc at the Buck Institute and the Department of Urology at UCSF and a co-author of the paper.

"Our goal is to find the best way to exploit the benefits of alpha-lipoic acid, which means we need to drill down into the mechanisms involved in its activity," Bose said.

Stoller is currently recruiting cystinuria patients for a clinical trial which will run for three years at UCSF. "While we have been able to improve surgical techniques for these patients over the last three decades, it's time that we solve the problem of these stones forming in the first place, and thus eliminate the need for surgery," he said.

Even though researchers plan to test alpha-lipoic acid on other genetic models of kidney stone disease, Stoller said it's not time for patients who have had "garden variety" kidney stones to rely on alpha-lipoic acid to prevent stone recurrence. Those stones are primarily composed of calcium; the supplement has not been tested in such animal models and may not work against them.

  1. Tiffany Zee et al., Alpha-lipoic acid prevents kidney stones in mouse model of rare genetic disease, Nature Medicine (2017) http:dx.doi.org/10.1038/nm.4280.

Source: Medindia

Cite this Article   close



Recommended Reading

Latest Health Watch

 Uncovering the Link Between Blood Pressure and Cognitive Decline
Researchers have identified specific brain regions that are damaged by high blood pressure and may contribute to cognitive decline and dementia development.
 Surprising Link Between Eye Color and Retinal Health
The same metabolites that regulate eye color may also impact the health of the retina. People with darker eyes may be less likely to develop certain eye diseases.
AI Predicts Breast Cancer Four Years Ahead of Time
Artificial intelligence detects breast cancer four years before its development.
Call Your Smartphone to Save Your Hearing
Smartphones, if used in the right way can be a boon to saving your hearing
Hope on the Horizon With Declining Suicide Rate in Europe
A recent study analyzed suicide rates in 38 European countries from 2011 to 2019 and found that 15 countries saw a decline, while others remained stable.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Alpha-lipoic Acid Prevents Kidney Stones in Rare Genetic Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests